Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg)

被引:8
作者
Shimada, S [1 ]
Aizawa, R [1 ]
Abe, H [1 ]
Suto, S [1 ]
Miyakawa, Y [1 ]
Alzawa, Y [1 ]
机构
[1] Jikei Univ, Aoto Hosp, Dept Internal Med, Div Gastroenterol & Hepatol,Katsushika Ku, Tokyo 1258506, Japan
关键词
HBV-DNA; anti-HBc; anti-HBs; anti-HCV; alcohol consumption; hepatocellular carcinoma;
D O I
10.2169/internalmedicine.42.389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To clarify risk factors for hepatocellular carcinoma (HCC) other than hepatitis B surface antigen (HBsAg). Patients and Methods We investigated serum HBV-DNA and other factors in 146 patients with liver cirrhosis (LC) or HCC who were HBsAg negative. We analyzed the clinical background of the patients, status of hepatitis B (HBV) viral markers and platelet count as well as the presence of an HBV-DNA fragment by PCR and elucidated risk factors for HCC generation using a logistic regression model. Results Among ten factors, we determined that four represented a significant risk for HBsAg negative HCC: male gender, total alcohol consumption, total cigarettes smoked, and the presence of an HBV-DNA fragment. Multivariate analysis showed that among the four factors, the HBV-DNA fragment was an independent factor associated with HCC. Conclusion The presence of an HBV-DNA fragment irrespective of the status of antibodies to either HBsAg (anti-HBs) or hepatitis B core antigen (anti-HBc) is a pivotal factor associated with the development of HCC.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 33 条
  • [1] Quantitation of hepatitis B virus genomic DNA by real-time detection PCR
    Abe, A
    Inoue, K
    Tanaka, T
    Kato, J
    Kajiyama, N
    Kawaguchi, R
    Tanaka, S
    Yoshiba, M
    Kohara, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) : 2899 - 2903
  • [2] Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.0.CO
  • [3] 2-6
  • [4] Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology
    Berasain, C
    Betés, M
    Panizo, A
    Ruiz, J
    Herrero, JI
    Civeira, MP
    Prieto, J
    [J]. GUT, 2000, 47 (03) : 429 - 435
  • [5] EVIDENCE THAT HEPATITIS-B VIRUS HAS A ROLE IN LIVER-CELL CARCINOMA IN ALCOHOLIC LIVER-DISEASE
    BRECHOT, C
    NALPAS, B
    COUROUCE, AM
    DUHAMEL, G
    CALLARD, P
    CARNOT, F
    TIOLLAIS, P
    BERTHELOT, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (23) : 1384 - 1387
  • [6] Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
    Cacciola, I
    Pollicino, T
    Squadrito, G
    Cerenzia, G
    Orlando, ME
    Raimondo, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) : 22 - 26
  • [7] Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection
    Chan, HLY
    Tsang, SWC
    Leung, NWY
    Tse, CH
    Hui, Y
    Tam, JSL
    Chan, FKL
    Sung, JJY
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (05) : 1211 - 1215
  • [8] High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology
    Chemin, I
    Zoulim, F
    Merle, P
    Arkhis, A
    Chevallier, M
    Kay, A
    Cova, L
    Chevallier, P
    Mandrand, B
    Trépo, C
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (03) : 447 - 454
  • [9] Hepatitis B virus with X gene mutation is associated with the majority of serologically ''silent'' non-B, non-C chronic hepatitis
    Fukuda, R
    Ishimura, N
    Kushiyama, Y
    Moriyama, N
    Ishihara, S
    Chowdhury, A
    Tokuda, A
    Sakai, S
    Akagi, S
    Watanabe, M
    Fukumoto, S
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1996, 40 (07) : 481 - 488
  • [10] Fukuda R, 1999, J MED VIROL, V58, P201, DOI 10.1002/(SICI)1096-9071(199907)58:3&lt